News – Nexo Therapeutics

Calico and Nexo Enter into Collaboration to Discover and Develop Small Molecule Therapies for Age-Related Diseases

May 21, 2026

SOUTH SAN FRANCISCO, Calif. and WATERTOWN, Mass., May 21, 2026 — Calico Life Sciences LLC (Calico), a clinical-stage biotechnology organization focused on aging and age-related diseases…

BioWorld: Nexo emerges with $60M series A, takes aim at ‘elusive’ targets

Aug 4, 2023

BioWorld

Go to the original article

MedCity News: Bio Startup Nexo Lands $60M to Climb to New Heights in Cancer Drug R&D

Jul 27, 2023

MedCity News

Go to the original article

Pharmaceutical Technology: Oncology company Nexo Therapeutics raises $60m in Series A round

Jul 27, 2023

Pharmaceutical Technology

Go to the original article

C&EN: Nexo launches with oncology drug discovery program

Jul 27, 2023

C&EN

Go to the original article

BioPharma Dive: Nexo allies with MD Anderson in pursuit of covalent cancer drugs

Jul 26, 2023

BioPharma Dive

Go to the original article

Nexo Therapeutics Launches With $60 Million Series A Financing

Jul 26, 2023

Nexo Therapeutics launched with $60 million in Series A funding led by Versant Ventures and outlined a platform designed to discover covalent drugs against previously intractable…

MD Anderson and Nexo Therapeutics announce strategic research collaboration to advance new therapies against intractable targets

Jul 26, 2023

MD Anderson and Nexo Therapeutics announced a multi-year collaboration that combines Nexo's discovery platform with MD Anderson's TRACTION capabilities to move new small-molecule cancer therapies toward…